These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 19926696)
1. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. Hippisley-Cox J; Coupland C BMJ; 2009 Nov; 339():b4229. PubMed ID: 19926696 [TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. Hippisley-Cox J; Coupland C BMJ; 2012 May; 344():e3427. PubMed ID: 22619194 [TBL] [Abstract][Full Text] [Related]
3. Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. Collins GS; Mallett S; Altman DG BMJ; 2011 Jun; 342():d3651. PubMed ID: 21697214 [TBL] [Abstract][Full Text] [Related]
4. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312 [TBL] [Abstract][Full Text] [Related]
5. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. Hippisley-Cox J; Coupland C BMC Fam Pract; 2010 Jun; 11():49. PubMed ID: 20565929 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study. Hippisley-Cox J; Coupland C BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232 [No Abstract] [Full Text] [Related]
7. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. Hippisley-Cox J; Coupland C; Brindle P BMJ; 2017 May; 357():j2099. PubMed ID: 28536104 [No Abstract] [Full Text] [Related]
8. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. Hippisley-Cox J; Coupland C BMJ; 2011 Aug; 343():d4656. PubMed ID: 21846713 [TBL] [Abstract][Full Text] [Related]
10. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. Livingstone SJ; Morales DR; McMinn M; Eke C; Donnan P; Guthrie B BMJ Med; 2022; 1(1):e000316. PubMed ID: 36936595 [TBL] [Abstract][Full Text] [Related]
11. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study. Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610 [TBL] [Abstract][Full Text] [Related]
12. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. Hippisley-Cox J; Coupland C; Brindle P BMJ; 2013 May; 346():f2573. PubMed ID: 23641033 [TBL] [Abstract][Full Text] [Related]
13. Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Livingstone SJ; Guthrie B; McMinn M; Eke C; Donnan PT; Morales DR Lancet Healthy Longev; 2023 Jan; 4(1):e43-e53. PubMed ID: 36610448 [TBL] [Abstract][Full Text] [Related]
14. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006 [TBL] [Abstract][Full Text] [Related]
15. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland]. Lippuner K Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study. Hippisley-Cox J; Coupland C BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428 [TBL] [Abstract][Full Text] [Related]
17. Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures. Weycker D; Edelsberg J; Barron R; Atwood M; Oster G; Crittenden DB; Grauer A Osteoporos Int; 2017 Sep; 28(9):2565-2571. PubMed ID: 28593447 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study. Hippisley-Cox J; Coupland C BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509 [No Abstract] [Full Text] [Related]
19. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway. Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994 [TBL] [Abstract][Full Text] [Related]
20. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Siris ES; Baim S; Nattiv A Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]